Clinical Trials · NCT06497595
Lifestyle Intervention to Reduce the Risk of Sarcopenia in Adults With Diabetes & Obesity Treated With Semaglutide
- Phase
- N/A
- Recruitment status
- Recruiting
- Sponsor
- Sheba Medical Center
- Enrollment
- 60
- Start date
- May 2025
- Locations
- 2 sites, Israel
- Primary endpoint
- Thigh muscle volume (TMV)